SPOT-MAS 男士8種早期癌症篩查 (HCDNA02)
SPOT-MAS是一种非侵入性的血液检测，用于筛查8种癌症，包括肺癌、乳腺癌、结肠癌等，通过循环肿瘤DNA技术结合次世代测序和人工智能分析。
- The description claims high accuracy, with a specificity of 99.8% and low false positive rates.
- The description claims it is the first test validated for Asians, based on a prospective study of 9,024 people.
- The description claims it can detect cancer earlier than imaging tests like X-ray or CT scans.
Specifications
- 服務地點
- 尖沙咀昇康滙, 旺角
Variants (2)
- 尖沙咀昇康滙 — 3160.00 HKD — In stock
- 旺角 — 3160.00 HKD — In stock
AI Readiness
Good foundation, but some important product data is still missing.
83%